Status:
COMPLETED
Prevalence of Contrast Enhancement of the Oculomotor Nerve on 3D PD T1 MRI Sequence in Patients With Ophthalmoplegia
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Ophthalmoplegia
Eligibility:
All Genders
18+ years
Brief Summary
Oculomotor nerve (third cranial nerve or "III") palsy is a relatively frequent cause of consultation in ophthalmology. It may reveal a life-threatening pathology such as aneurysm rupture, pituitary a...
Eligibility Criteria
Inclusion
- \- Ophthalmoplegia whatever the clinical form (unilateral or not, isolated or not, sudden or progressive onset)
Exclusion
- Absolute contraindication to MRI or injection of contrast agents.
Key Trial Info
Start Date :
October 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 16 2021
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT03269682
Start Date
October 20 2017
End Date
April 16 2021
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation Ophtalmologique A. de Rothschild
Paris, France, 75019